Showing results (431-440 of 456) with videos related to
Sort By:
Pageof 46
Alimentary Pharmacology & Therapeutics|May 21, 2025
Distribution, Characteristics, and Natural History of Diverse Types of Indeterminate Chronic Hepatitis B: A REAL-B StudyRui Huang, Ai-Thien Do, Hidenori Toyoda, et al.Scientific Reports|March 28, 2020
Sustained virological response to hepatitis C therapy does not decrease the incidence of systemic lupus erythematosus or rheumatoid arthritisWei-Fan Hsu, Chi-Yi Chen, Kuo-Chih Tseng, et al.Hepatology International|November 25, 2021
Longitudinal renal changes in chronic hepatitis B patients treated with entecavir versus TDF: a REAL-B studyLung-Yi Mak, Joseph Hoang, Dae Won Jun, et al.Hepatology International|July 6, 2020
Pre-existing liver disease is associated with poor outcome in patients with SARS CoV2 infection; The APCOLIS Study (APASL COVID-19 Liver Injury Spectrum Study)Shiv Kumar Sarin, Ashok Choudhury, George K Lau, et al.Journal of Gastroenterology and Hepatology|May 8, 2021
Hepatitis C virus eradication decreases the risks of liver cirrhosis and cirrhosis-related complications (Taiwanese chronic hepatitis C cohort)Wei-Fan Hsu, Pei-Chein Tsai, Chi-Yi Chen, et al.Journal of Gastroenterology and Hepatology|February 24, 2021
Long-term risk of end-stage renal diseases with maintenance dialysis among chronic hepatitis C patients after antiviral therapy in TaiwanMeng-Hsuan Hsieh, Ming-Jong Bair, Pei-Chien Tsai, et al.Journal of the Formosan Medical Association = Taiwan Yi Zhi|March 1, 2025
Posttreatment FIB-4 score change predicts hepatocellular carcinoma in chronic hepatitis C patients: Findings from the Taiwan hepatitis C registry programHung-Wei Wang, Yu-Syuan Zeng, Chung-Feng Huang, et al.Hepatology International|September 7, 2022
Effectiveness of entecavir vs tenofovir disoproxil fumarate for functional cure of chronic hepatitis B in an international cohortYao-Chun Hsu, Dae Won Jun, Cheng-Yuan Peng, et al.Eclinicalmedicine|August 20, 2025
Impact of metabolic dysfunction on treatment responses to nucleos(t)ide analogues in chronic hepatitis B: a retrospective multi-center REAL-B cohort studyRui Huang, Dae Won Jun, Hidenori Toyoda, et al.Clinical and Molecular Hepatology|March 17, 2025
Impact of components of metabolic syndrome on long-term outcomes of CHB with nucleos(t)ide analogue treatmentRui Huang, Dae Won Jun, Hidenori Toyoda, et al.Pageof 46